Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women

G. B. Melis, M. Gambacciani, A. M. Paoletti, F. Beneventi, V. Mais, P. Baroldi, P. Fioretti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences